{
  "title": "Delineate innate immune responses in populations at risk (the elderly and the immunosuppressed) that are different from the general population",
  "identifier": {
    "identifier": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY40",
    "identifierSource": "http://www.immport.org"
  },
  "producedBy": {  "name": "Delineate innate immune responses in populations at risk (the elderly and the immunosuppressed) that are different from the general population",
  "performedBy": [
    {
      "firstName": "Erol",
      "lastName": "Fikrig",
      "email": "?",
      "affiliations": [
          {
             "name": "Yale School of Medicine"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "firstName": "Norma",
      "lastName": "Andrews",
      "email": "?",
      "affiliations": [
          {
             "name": "?"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    },
    {
      "firstName": "Jorge",
      "lastName": "Galan",
      "email": "?",
      "affiliations": [
          {
             "name": "?"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    },
    {
      "firstName": "John",
      "lastName": "MacMicking",
      "email": "?",
      "affiliations": [
          {
             "name": "?"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    },
    {
      "firstName": "Craig",
      "lastName": "Roy",
      "email": "?",
      "affiliations": [
          {
             "name": "?"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    }
  ],
  "studyGroups": [
        {
          "name": "Young Adults",
          "size": 372
        },
        {
          "name": "Elderly",
          "size": 386
        },
        {
          "name": "Immunocompromised",
          "size": 145
        }
  ],
  
  "usesReagent": [
        {
          "name": "BD OptELA Human IL-8 ELISA Set"
        },
        {
          "name": "BD OptELA Human TNF ELISA Set"
        },
        {
          "name": "TaqMan Universal PCR Master Mix"
        },
        {
          "name": "20X Assays-On-Demand SNP Genotyping Assay Mix"
        },
        {
          "name": "Supermix"
        },
        {
          "name": "CATTF primer"
        },
        {
          "name": "CATTR primer"
        },
        {
          "name": "MIF protein"
        },
        {
          "name": "MIF antibody"
        },
        {
          "name": "PE-Cy5 anti-human CD4 (RPA-T4)"
        },
        {
          "name": "PE Mouse IgG1, kappa Isotype Control, Clone: MOPC-21"
        },
        {
          "name": "FITC Mouse IgG2a, kappa Isotype Control, Clone: G155-178"
        },
        {
          "name": "Phycoerythrin (PE) anti-human Toll-like receptor 1 (CD281, TLR1)"
        },
        {
          "name": "Fluorescein isothiocyanate (FITC) anti-human Toll-like receptor 2 (CD282, TLR2, TLR-2)"
        },
        {
          "name": "Phycoerythrin (PE) anti-human Toll-like receptor 4 (CD284, TLR4, TLR-4)"
        },
        {
          "name": "IgG from goat serum"
        },
        {
          "name": "FITC Donkey Anti-Goat IgG (H+L)"
        },
        {
          "name": "Rat IgG2a K Isotype Control Biotin"
        },
        {
          "name": "Streptavidin-PE"
        },
        {
          "name": "goat-anti-human-TLR5"
        },
        {
          "name": "Anti-Human CD286 (TLR6) Biotin"
        },
        {
          "name": "Flagellin"
        },
        {
          "name": "Phospho R anti NF-kB p65(SER536)"
        },
        {
          "name": "NF-kB p65"
        },
        {
          "name": "Phospho p38 MAP(Tyr180/182)"
        },
        {
          "name": "p38 MAP Kinase"
        },
        {
          "name": "IKK-alpha"
        },
        {
          "name": "Phospho ERK1/2(p44/42)"
        },
        {
          "name": "ERK 1"
        },
        {
          "name": "Actin"
        },
        {
          "name": "beta-Actin Fwd Primers"
        },
        {
          "name": "beta-Actin Rev Primers"
        },
        {
          "name": "beta-Actin F Probe"
        },
        {
          "name": "TLR1, Hs00413978_m1"
        },
        {
          "name": "TLR2, Hs01014511_m1"
        },
        {
          "name": "TLR4, Hs00152939_m1"
        },
        {
          "name": "TLR5, Hs01920773_s1"
        },
        {
          "name": "TLR6, Hs00271977_s1"
        },
        {
          "name": "CD14 MicroBeads"
        },
        {
          "name": "MS Columns"
        },
        {
          "name": "MiniMACS Separator"
        },
        {
          "name": "TLR3 F Primers"
        },
        {
          "name": "TLR3 Rev Primers"
        },
        {
          "name": "TLR3 Probe"
        },
        {
          "name": "TLR7 Fwd Primers"
        },
        {
          "name": "TLR7 Rev Primers"
        },
        {
          "name": "TLR7 Probe"
        },
        {
          "name": "TLR8 Fwd Primers"
        },
        {
          "name": "TLR8 Rev Primers"
        },
        {
          "name": "TLR8 Probe"
        },
        {
          "name": "TLR9 Fwd Primers"
        },
        {
          "name": "TLR9 Rev Primers"
        },
        {
          "name": "TLR9 Probe"
        },
        {
          "name": "Lineage cocktail 1 (lin 1) - CD3, CD14, CD16, CD19, CD20, CD56 FITC"
        },
        {
          "name": "Anti-Human HLA-DR PerCP"
        },
        {
          "name": "Anti-Human CD11c PE"
        },
        {
          "name": "Anti-Human CD123 PE-Cy7"
        },
        {
          "name": "anti-human CD80 FITC"
        },
        {
          "name": "Phycoerythrin-Cy7 anti human HLA-DR"
        },
        {
          "name": "HU CD86 PE MAB"
        },
        {
          "name": "HU CD16 APC-CY7 MAB"
        },
        {
          "name": "HU CD3 APC-CY7 MAB"
        },
        {
          "name": "HU CD11C APC MAB"
        },
        {
          "name": "HuCD123 PE-CY5 MAB"
        },
        {
          "name": "mouse monoclonal anti-human alpha-2-interferon (FITC)"
        },
        {
          "name": "PE rat IgG2a Iso Cntr"
        },
        {
          "name": "Alexa Fluor 700 Mouse IgG2a, K Isotype Control"
        },
        {
          "name": "Pacific Blue anti human IL12"
        },
        {
          "name": "APC-CY 7 Mouse Anti CD14"
        },
        {
          "name": "APC-CY 7 Mouse anti human CD19"
        },
        {
          "name": "Protein Transport Inhibitor (Containing Brefeldin A)"
        },
        {
          "name": "anti human IL12 PE"
        },
        {
          "name": "anti human TLR9 PE"
        },
        {
          "name": "anti human TLR1 PE"
        },
        {
          "name": "anti human TLR2 FITC"
        },
        {
          "name": "anti human TLR3 PE"
        },
        {
          "name": "HU TNF Alexa 700"
        },
        {
          "name": "HU IL6 PE"
        }
  ],
  
  "selectionCriteria": [
        {
          "category": "Inclusion",
          "values": [
              "Ambulatory older subjects who are not nursing home residents"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Subjects with acute infection (fever and symptoms within 2 weeks of enrollment)"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Taking 10mg or more of  Prednisone daily for at least one month"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Have illnesses such polymyalgia rheumatica, rheumatoid arthritis, and systemic lupus erythematosus, and at least for the latter two illnesses"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Taking other drugs considered in immunosuppression in addition to Prednisone such as plaquenil, sulfasalzine, methotrexate, immuran, cytoxan, tacrolimus, mycophenolate mofetil, other chemotherapeutic agents and other  chemotherapeutic agents"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Organ transplantation subjects"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Malignancy other than localized skin cancer subjects"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Nonmetastatic  prostate cancer subjects"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Asplenia subjects"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Dysglobulinemia subjects"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Cirrhosis subjects"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Renal failure requiring hemodialysis"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "All genders and ethnic groups"
          ]
        }
  ],
  
  "types": [
      {
          "value": "Observational"
      }
  ]
  },
  "creators": [
    {
      "firstName": "Erol",
      "lastName": "Fikrig",
      "email": "?",
      "affiliations": [
          {
             "name": "Yale School of Medicine"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "name": "Innate Immune Responsiveness in the Elderly and the Immunosuppressed",
      "extraProperties": [
        {
          "category": "Catgory",
          "values": [
            {
              "value": "DAIT"
            }
          ]
        },
        {
          "category": "External Id",
          "values": [
            {
              "value": "N01-AI-050031"
            }
          ]
        },
        {
          "category": "Description",
          "values": [
            {
              "value": "This proposal will explore the hypothesis that altered innate immune responses in the elderly and the immunosuppressed contribute to vaccine unresponsiveness and disease susceptibility.  We will first (Aim 1) assess the levels of TLR expression and the efficiency of TLR responsiveness in younger adults versus elderly or immunosuppressed populations. In addition, we will assess the effect of aging on macrophage migration inhibitory factor (MIF), a TLR-responsive mediator that critically regulates monocyte/macrophage activation responses and downstream cytokine production.  We will then (Aim 2) assess the effects of these impairments in innate immunity, identified in Aim 1, on the efficiency of the response to Biodefense priority pathogens, using West Nile virus infection and influenza vaccination as models. These studies will lead to a greater understanding of how alterations in innate immune responses in high-risk populations such as in the elderly and the immunosuppressed contribute to disease susceptibility and vaccine responsiveness.  Understanding of these mechanisms of impaired host defense will be of general benefit, particularly given the potential for the emergence of new pathogens or outbreaks (including the widened range of mosquito vectors harboring West Nile virus in the United States) or the engineering of virulent or drug resistant agents for bioterorrism.  http://projectreporter.nih.gov/project_info_details.cfm?aid=7337892&icde=23814545&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC"
            }
          ]
        }
      ]
    }
  ],
  
  "primaryPublications": [
    {
      "identifier":
        {
          "identifier": "17202359",
          "identifierSource": "pubmed"
        },
      "authorsList": "van Duin D(1), Mohanty S, Thomas V, Ginter S, Montgomery RR, Fikrig E, Allore HG, Medzhitov R, Shaw AC.",
      "title": "Age-associated defect in human TLR-1/2 function.",
      "publicationVenue": "J Immunol.",
      "dates": [
        {
          "date": "2007",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "17471428",
          "identifierSource": "pubmed"
        },
      "authorsList": "van Duin D(1), Allore HG, Mohanty S, Ginter S, Newman FK, Belshe RB, Medzhitov R, Shaw AC.",
      "title": "Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults.",
      "publicationVenue": "J Infect Dis.",
      "dates": [
        {
          "date": "2007",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "17767688",
          "identifierSource": "pubmed"
        },
      "authorsList": "van Duin D(1), Shaw AC.",
      "title": "Toll-like receptors in older adults.",
      "publicationVenue": "J Am Geriatr Soc.",
      "dates": [
        {
          "date": "2007",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "17909632",
          "identifierSource": "pubmed"
        },
      "authorsList": "Arjona A(1), Foellmer HG, Town T, Leng L, McDonald C, Wang T, Wong SJ, Montgomery RR, Fikrig E, Bucala R.",
      "title": "Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion.",
      "publicationVenue": "J Clin Invest.",
      "dates": [
        {
          "date": "2007",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "18056386",
          "identifierSource": "pubmed"
        },
      "authorsList": "Arjona A(1), Ledizet M, Anthony K, Bonaf?, Modis Y, Town T, Fikrig E.",
      "title": "West Nile virus envelope protein inhibits dsRNA-induced innate immune responses.",
      "publicationVenue": "J Immunol.",
      "dates": [
        {
          "date": "2007",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "18256150",
          "identifierSource": "pubmed"
        },
      "authorsList": "Dai J(1), Wang P, Bai F, Town T, Fikrig E.",
      "title": "Icam-1 participates in the entry of west nile virus into the central nervous system.",
      "publicationVenue": "J Virol.",
      "dates": [
        {
          "date": "2008",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "18355125",
          "identifierSource": "pubmed"
        },
      "authorsList": "Kong KF(1), Wang X, Anderson JF, Fikrig E, Montgomery RR.",
      "title": "West nile virus attenuates activation of primary human macrophages.",
      "publicationVenue": "Viral Immunol.",
      "dates": [
        {
          "date": "2008",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "18508883",
          "identifierSource": "pubmed"
        },
      "authorsList": "Kong KF(1), Delroux K, Wang X, Qian F, Arjona A, Malawista SE, Fikrig E, Montgomery RR.",
      "title": "Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly.",
      "publicationVenue": "J Virol.",
      "dates": [
        {
          "date": "2008",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "18632868",
          "identifierSource": "pubmed"
        },
      "authorsList": "Wang P(1), Dai J, Bai F, Kong KF, Wong SJ, Montgomery RR, Madri JA, Fikrig E.",
      "title": "Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain.",
      "publicationVenue": "J Virol.",
      "dates": [
        {
          "date": "2008",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "18690214",
          "identifierSource": "pubmed"
        },
      "authorsList": "Krishnan MN(1), Ng A, Sukumaran B, Gilfoy FD, Uchil PD, Sultana H, Brass AL, Adametz R, Tsui M, Qian F, Montgomery RR, Lev S, Mason PW, Koski RA, Elledge SJ,  Xavier RJ, Agaisse H, Fikrig E.",
      "title": "RNA interference screen for human genes associated with West Nile virus infection.",
      "publicationVenue": "Nature.",
      "dates": [
        {
          "date": "2008",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "19200759",
          "identifierSource": "pubmed"
        },
      "authorsList": "Town T(1), Bai F, Wang T, Kaplan AT, Qian F, Montgomery RR, Anderson JF, Flavell  RA, Fikrig E.",
      "title": "Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing.",
      "publicationVenue": "Immunity.",
      "dates": [
        {
          "date": "2009",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "19346297",
          "identifierSource": "pubmed"
        },
      "authorsList": "Yende S(1), Angus DC, Kong L, Kellum JA, Weissfeld L, Ferrell R, Finegold D, Carter M, Leng L, Peng ZY, Bucala R.",
      "title": "The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia.",
      "publicationVenue": "FASEB J.",
      "dates": [
        {
          "date": "2009",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "19541535",
          "identifierSource": "pubmed"
        },
      "authorsList": "Panda A(1), Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, Lord JM, Shaw AC.",
      "title": "Human innate immunosenescence: causes and consequences for immunity in old age.",
      "publicationVenue": "Trends Immunol.",
      "dates": [
        {
          "date": "2009",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "19816558",
          "identifierSource": "pubmed"
        },
      "authorsList": "Bai F(1), Town T, Qian F, Wang P, Kamanaka M, Connolly TM, Gate D, Montgomery RR, Flavell RA, Fikrig E.",
      "title": "IL-10 signaling blockade controls murine West Nile virus infection.",
      "publicationVenue": "PLoS Pathog.",
      "dates": [
        {
          "date": "2009",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "20100933",
          "identifierSource": "pubmed"
        },
      "authorsList": "Panda A(1), Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle V, Belshe RB, Fikrig E, Allore HG, Montgomery RR, Shaw AC.",
      "title": "Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response.",
      "publicationVenue": "J Immunol.",
      "dates": [
        {
          "date": "2010",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "20404807",
          "identifierSource": "pubmed"
        },
      "authorsList": "Mathai SK(1), Gulati M, Peng X, Russell TR, Shaw AC, Rubinowitz AN, Murray LA, Siner JM, Antin-Ozerkis DE, Montgomery RR, Reilkoff RA, Bucala RJ, Herzog EL.",
      "title": "Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.",
      "publicationVenue": "Lab Invest.",
      "dates": [
        {
          "date": "2010",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "20596538",
          "identifierSource": "pubmed"
        },
      "authorsList": "Dunne DW(1), Shaw A, Bockenstedt LK, Allore HG, Chen S, Malawista SE, Leng L, Mizue Y, Piecychna M, Zhang L, Towle V, Bucala R, Montgomery RR, Fikrig E.",
      "title": "Increased TLR4 expression and downstream cytokine production in immunosuppressed  adults compared to non-immunosuppressed adults.",
      "publicationVenue": "PLoS One.",
      "dates": [
        {
          "date": "2010",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "20667703",
          "identifierSource": "pubmed"
        },
      "authorsList": "Shaw AC(1), Joshi S, Greenwood H, Panda A, Lord JM.",
      "title": "Aging of the innate immune system.",
      "publicationVenue": "Curr Opin Immunol.",
      "dates": [
        {
          "date": "2010",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "20818395",
          "identifierSource": "pubmed"
        },
      "authorsList": "Wang P(1), Arjona A, Zhang Y, Sultana H, Dai J, Yang L, LeBlanc PM, Doiron K, Saleh M, Fikrig E.",
      "title": "Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I.",
      "publicationVenue": "Nat Immunol.",
      "dates": [
        {
          "date": "2010",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "21050124",
          "identifierSource": "pubmed"
        },
      "authorsList": "Bai F(1), Kong KF, Dai J, Qian F, Zhang L, Brown CR, Fikrig E, Montgomery RR.",
      "title": "A paradoxical role for neutrophils in the pathogenesis of West Nile virus.",
      "publicationVenue": "J Infect Dis.",
      "dates": [
        {
          "date": "2010",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "21398396",
          "identifierSource": "pubmed"
        },
      "authorsList": "Qian F(1), Wang X, Zhang L, Lin A, Zhao H, Fikrig E, Montgomery RR.",
      "title": "Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus.",
      "publicationVenue": "J Infect Dis.",
      "dates": [
        {
          "date": "2011",
          "type": { "value": "publication year" }
        }
      ]
    },
    {
      "identifier":
        {
          "identifier": "22023165",
          "identifierSource": "pubmed"
        },
      "authorsList": "Qian F(1), Wang X, Zhang L, Chen S, Piecychna M, Allore H, Bockenstedt L, Malawista S, Bucala R, Shaw AC, Fikrig E, Montgomery RR.",
      "title": "Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly.",
      "publicationVenue": "Aging Cell.",
      "dates": [
        {
          "date": "2012",
          "type": { "value": "publication year" }
        }
      ]
    }
  ],
  "types": [
      {
        "value": "Observational"
      },
      {
        "value": "Infection Response"
      }
  ],
  "dates": [
      {
          "date": "2013-06-12",
          "type": {
              "value": "final_public_release_date"
          }
      }
  ],
  "availability": "Available for download after registration with ImmPort",
  "refinement": "Curated",
  "dimensions": [{
        "name": {
            "value": "Cytokine Quantification"
        },
        "description": "Examine the cytokine levels from supernatants of unstimulated and stimulated monocytes. After 20 hours stimulation with TLR ligands, the culture supernatants are assayed for IL-8 by ELISA. TLR stimulation: N-Palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-[R]-Cys-[S]-Serl-[S]-Lys(4) trihydrochloride (Pam3CSK4 5 ug/ml; TLR1/2), Lipoteichoic acid (LTA; 1 ug/ml; TLR2/6), Lipopolysaccharide (LPS, 0.5 ug/ml; TLR4) and Flagellin from Salmonella typhimurium (2.5 ug/ml; TLR5) will be used.",
        "types": [
            {
               "value": "ELISA"
            }
        ]
      },{
        "name": {
            "value": "Cytokine Quantification"
        },
        "description": "Examine the cytokine levels from supernatants of unstimulated and stimulated monocytes. After 20 hours stimulation with TLR ligands, the culture supernatants are assayed for TNF-alpha by ELISA. TLR stimulation: N-Palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-[R]-Cys-[S]-Serl-[S]-Lys(4) trihydrochloride (Pam3CSK4 5 ug/ml; TLR1/2), Lipoteichoic acid (LTA; 1 ug/ml; TLR2/6), Lipopolysaccharide (LPS, 0.5 ug/ml; TLR4) and Flagellin from Salmonella typhimurium (2.5 ug/ml; TLR5) will be used.",
        "types": [
            {
               "value": "ELISA"
            }
        ]
      },{
        "name": {
            "value": "Genotyping"
        },
        "description": "Monocytes/macrophages cells from adult, elderly, and immunosuppressed subjects, define their MIF genotype, and analyze their baseline and stimulus-induced production of MIF. Patient samples for genotyping will be obtained from the pellet of the Ficoll-hypaque isolation of PBMCs and extracted DNA will be analyzed for MIF genotype by established, robotic methodology that requires < 1 ug of DNA (Genes Immun 3:170-176). Purified monocytes/macrophage then will be studied for their baseline and stimulation-induced responses following protocols in place in our laboratory. We will define the MIF genotype (low versus high expression MIF alleles) in the adult, elderly, and immunosuppressed subjects, and determine whether any deviation in MIF production or MIF-dependent activation parameters (TLR expression, downstream pro-inflammatory cytokine production) is associated with particular MIF alleles.",
        "types": [
            {
               "value": "PCR"
            }
        ]
      },{
        "name": {
            "value": "Genotyping"
        },
        "description": "Monocytes/macrophages cells from adult, elderly, and immunosuppressed subjects, define their MIF genotype, and analyze their baseline and stimulus-induced production of MIF. Patient samples for genotyping will be obtained from the pellet of the Ficoll-hypaque isolation of PBMCs and extracted DNA will be analyzed for MIF genotype by established, robotic methodology that requires < 1 ug of DNA (Genes Immun 3:170-176). Purified monocytes/macrophage then will be studied for their baseline and stimulation-induced responses following protocols in place in our laboratory. We will define the MIF genotype (low versus high expression MIF alleles) in the adult, elderly, and immunosuppressed subjects, and determine whether any deviation in MIF production or MIF-dependent activation parameters (TLR expression, downstream pro-inflammatory cytokine production) is associated with particular MIF alleles.",
        "types": [
            {
               "value": "PCR"
            }
        ]
      },{
        "name": {
            "value": "Cytokine Quantification"
        },
        "description": "Examine the cytokine levels from supernatants of unstimulated and stimulated monocytes. After 20 hours stimulation with TLR ligands, the culture supernatants are assayed for MIF by ELISA. TLR stimulation: N-Palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-[R]-Cys-[S]-Serl-[S]-Lys(4) trihydrochloride (Pam3CSK4 5 ug/ml; TLR1/2), Lipoteichoic acid (LTA; 1 ug/ml; TLR2/6), Lipopolysaccharide (LPS, 0.5 ug/ml; TLR4) and Flagellin from Salmonella typhimurium (2.5 ug/ml; TLR5) will be used.",
        "types": [
            {
               "value": "ELISA"
            }
        ]
      },{
        "name": {
            "value": "Cellular Phenotype"
        },
        "description": "Examine cell surface expression of TLR1, TLR2, TLR4, TLR5 and TLR6 by FACS staining.  Monocytes will be gated for CD4 dim population",
        "types": [
            {
               "value": "Flow Cytometry"
            }
        ]
      },{
        "name": {
            "value": "Protein Quantification"
        },
        "description": "To determine the mechanism of any impairment detected in TLR signaling, selected subjects will be sampled again for assay of signaling mechanisms. We will compare the induction of these factors, from monocytes of adult and elderly subjects in response to stimulation with TLR ligand. Adherent monocytes will be stimulated with TLR ligands for 10 min. Cell lysates from 1 x10e6 cells/well in 6 well plates will be assayed by standard assays.  Cells will then be lysed for Western Blot analysis to examine total and phosphorylated levels of NF-kB p65, p38, ERK, and IkBa.",
        "types": [
            {
               "value": "Western Blot"
            }
        ]
      },{
        "name": {
            "value": "Molecular Quantification"
        },
        "description": "Examine mRNA expression of TLRs1-9 by Q-PCR in human monocytes and blood DCs",
        "types": [
            {
               "value": "Q-PCR"
            }
        ]
      },{
        "name": {
            "value": "Molecular Quantification"
        },
        "description": "Examine mRNA expression of TLRs1-9 by Q-PCR in human monocytes and blood DCs",
        "types": [
            {
               "value": "Q-PCR"
            }
        ]
      },{
        "name": {
            "value": "Protein Quantification"
        },
        "description": "Examine age-related differences in surface TLR expression in dendritic cells by FACS.",
        "types": [
            {
               "value": "Flow Cytometry"
            }
        ]
      },{
        "name": {
            "value": "Cytokine Quantification"
        },
        "description": "Examine cell surface expression of TLRs1-9 by FACS staining and the costimulatory molecules, CD80 and CD86",
        "types": [
            {
               "value": "Flow Cytometry"
            }
        ]
      }
      
  ],
  "isAbout": [
        {
          "name": "No Stimulation Control"
        },
        {
          "name": "Pam3CSK4 - ELISA"
        },
        {
          "name": "Poly(I:C) - ELISA"
        },
        {
          "name": "Lipopolysaccharide - ELISA"
        },
        {
          "name": "Poly(U) - ELISA"
        },
        {
          "name": "Lipoteichoic acid - ELISA"
        },
        {
          "name": "IFN-gamma - ELISA"
        },
        {
          "name": "CpG-ODN2216 - prevaccine"
        },
        {
          "name": "Flagellin - prevaccine"
        },
        {
          "name": "Isotype Control"
        },
        {
          "name": "Lipoteichoic acid - prevaccine"
        },
        {
          "name": "Pam3CSK4 - prevaccine"
        },
        {
          "name": "Poly(I:C) - prevaccine"
        },
        {
          "name": "R848 - prevaccine"
        }
  ],
  "distributions": [
      {
          "identifier": {
              "identifier": "SDY40",
              "identifierSource": "ImmPort"
          },
          "title": "Delineate innate immune responses in populations at risk (the elderly and the immunosuppressed) that are different from the general population",
          "access": {
              "landingPage": "http://www.immport.org",
              "accessURL": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY40",
              "types": [
                  {
                      "value": "Download tab separated files"
                  },
                  {
                      "value": "Download MySQL files and schema"
                  }
              ],
              "authorizations": [
                {
                    "value": "Registraton with ImmPort required"
                }
              ]
          },
          "storedIn": {
              "name": "ImmPort",
              "types": [
                {
                  "value": "primary repository"
                }
              ]
         },
         "licenses": [
           {
             "name": "ImmPort User Agreement",
             "version": "1.0",
             "extraProperties": [
               {
                 "category": "Link to User Agreement",
                 "values": [
                   {
                     "value": "http://www.immport.org/agreement"
                   }
                 ]
               }
             ]
           }
         ]
      }
  ],
  "acknowledges": [
    {
      "identifier": {
        "identifier": ""
      },
      "name": "Innate Immune Responsiveness in the Elderly and the Immunosuppressed",
      "extraProperties": [
        {
          "category": "Link",
          "values": [
            {
              "value": "None"
            }
          ]
        }
      ]}
  ],
  "licenses": [
    {
      "name": "ImmPort User Agreement",
      "version": "1.0",
      "extraProperties": [
        {
          "category": "Link to User Agreement",
          "values": [
            {
              "value": "http://www.immport.org/agreement"
            }
          ]
        }
      ]
    }
  ],
  "description": "We will assess the efficiency of the immune response of monocytes and dendritic cells in different populations (young adult and elderly) in response to stimulation with specific TLR ligands.  We will focus separately on TLRs 3, 7, 8, 9, that recognize viral targets, TLRs 1, 2, 4, 6 (bacterial targets), and the effects of aging on MIF.<br/><br/>We will quantify TLR expression as well as efficiency of signaling pathways triggered by TLR engagement to identify mechanisms that contribute to the impairments of innate immunity associated with aging and immunosuppression.<br/><br/>Finally, we will assess the functional and genetic polymorphisms of MIF in the innate response to TLR stimulation."
}
